Speaker Name: Prof. Piotr Ponikowski, Rector of Wroclaw Medical University, Director of the Institute for Heart Diseases, University Hospital, Wroclaw, Poland.

Watch the session to:

• Consider personalized GDMT in HF based on HR, BP, comorbidities, and CV risk.
• Get familiar with major HF comorbidities, including AF, CKD, DM, COPD, obesity, and depression.
• Understand initiation strategies for ACEi/ARB/ARNI, BB, and MRA in hospitalized high-risk patients.
• Interpret therapy selection using HR, BP, rhythm status, and renal function.
• Explore the role of SGLT2 inhibitors and NT-proBNP in optimizing outcomes across HF phenotypes.